AzTrials
AzTrials

Family MembersFAMESNCT06945055

FAmily Engagement Strategy for Coordinated Specialty Care

A study testing FAMES in people with Family Members and Implementation, run by Washington State University at 4 sites in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Family members/support persons' engagement in mental health services has been linked to reduced burden and stress and improves engagement and outcomes in individuals in the early stages of psychosis. The goal of FAMES is to address low family member/support person engagement in services. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Family Members, Implementation
What is being tested?
FAMES
Could I receive a placebo?
No, everyone receives an active treatment
How many people
900 participants
Where
4 sitesUnited States
Study dates
1 Mar 2025to Dec 2029
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

None listed.

Who cannot join

  • If they do not understand the consent process.
  • If they do not speak and/or understand English or Spanish.
  • Primary Service User Inclusion Criteria
  • enrolled in coordinated specialty care services for less than or equal to 6 months.
  • 15 years of age or older.
  • Has a family member/support person willing to engage in the study. during the active implementation period (FAMES) did not participate in the attention control condition.
  • if they do not understand the consent process
  • If they do not speak and/or understand English or Spanish

Trial locations and contacts

4 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Oladunni Oluwoye, Associate Professor, Ph.D. contact

509-368-6805

oladunni.oluwoye@wsu.edu

Bryony Stokes, Program Manager, M.S. contact

509-505-7001

bryony.mueller@wsu.edu

United States4 sites, 4 recruiting
  • Deschutes County Behavioral Health EASA

    Bend, Oregon, 97703

    Shannon Brister-Raugust, 541-322-7545, shannon.brister@deschutes.org

    Not yet recruiting
  • Comprehensive Healthcare

    Pasco, Washington, 99301

    Lucinda Sanchez, 5094121051, lucinda.sanchez@comphc.org

    Recruiting
  • Lucid Living

    Tacoma, Washington, 98418

    Gregory Jones, DNP, 360-539-8899, gregory@transitionalcare.net

    Recruiting
  • Comprehensive Healthcare

    Yakima, Washington, 98902

    Victor Larios, MSW, 5095754084, victor.larios@comphc.org

    Recruiting

Other trials in United States

About this study

Official title: Integration of a Culturally Responsive Family Peer Delivered Engagement Strategy in Coordinated Specialty Care

Family members/support persons' engagement in mental health services has been linked to reduced burden and stress and improves engagement and outcomes in individuals in the early stages of psychosis. The goal of FAMES is to address low family member/support person engagement in services. FAMES will also address disparities in coordinated specialty care (CSC) by using a culturally responsive family engagement strategy to be delivered by family peers.

Read the detailed description

The overall goal of this mixed-methods, clustered stepped-wedged designed study is to examine the effectiveness of a family peer implemented in coordinated specialty care programs at engaging family members in services. The use of a family peer is anticipated to increase family member participant's feelings of connectedness, self-efficacy, and motivation which will in turn improve family member participants engagement in scheduled coordinated specialty care services such as family psychoeducation.

Recruitment will consist of dyads compromised of a family member support person and a corresponding individual receiving coordinated specialty care services. Recruitment will occur over two waves, the attention control condition (ACC) and the FAMES condition. The ACC will last for 18 months and will recruit 225 participant dyads during which time family member participants will be contacted weekly for 12 weeks where they will be provided with positively framed messaging, educational materials around psychosis, tips for addressing relevant concerns in areas such as communication and de-escalation, and a list of community-based and online resources and events. The FAMES condition will last for 30 months and will recruit 225 participant dyads during which time family member participants will receive a modified cultural formulation interview, brief check-ins, psychoeducation, and will have access to an online community.

Recruitment will take place at nine coordinated specialty care programs across four states (Washington, Oregon, Tennessee, and New Mexico) which have been randomized to a clustered stepped wedge program design.

Being tested
FAMES, Control
Keywords
early psychosis, family peer, engagement
Medical subject headings
Psychotic Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • FAMESBehavioural

    225 dyads (family member/support persons and individuals receiving services for psychosis) will be recruited over a period of 30 months. Family member/support persons will be connected to a family peer for a period of 12 weeks who will use the cultural formulated interview to develop rapport and identify unique cultural needs which can inform treatment and resource identification. Participants will receive brief contact, family psychoeducation, and be connected to an online family resource group where they can receive additional support from certified peers and other family member/support persons.

  • ControlBehavioural

    participants will receive 12 weeks of automated communication which contain positive messaging, appointment reminders, links to community resources, and coping skills.

Study groups in NCT06945055
Study groupRoleWhat they receive
Attention Control ConditionActive comparator225 dyads (family members/support persons and individuals receiving services for psychosis) will be recruited over a period of 18 months to receive 12 weeks of weekly communication via text, email or phone call, which includes positive messaging, community resources, appointment reminders, and psychoeducation.
Receives: Behavioral: Control
Active ConditionActive comparatorThis arm lasts for 30 months during each wave of the clustered randomized stepped wedge design. 225 participants will receive the FAMES intervention.
Receives: Behavioral: FAMES

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Engagement in coordinated specialty care psychoeducation

    Will be measured as first session attendance rate and total attendance rate per family provided by administrative data from the coordinated specialty care site partners.

    Measured: Baseline through study completion; repeated measure to assess change through study completion, average of 3 months

  2. Engagement in Family Engagement Strategy

    Total number of Family Engagement Strategy session attended and the total number of contact minutes to measure engagement.

    Measured: Baseline through study completion; repeated measure to assess change through study completion, average of 3 months

Secondary outcomes (6)
  1. Perceived Stress Scale

    A self-report measure which includes 10 Likert-style items to assess the degree to which an individual appraises life as stressful. Scores range from 0-40 where scores greater that 13 indicate moderate to high perceived stress.

    Measured: Baseline through study completion; repeated measure to assess change through study completion, average of 6 months

  2. General Anxiety Disorder - 7

    Self-report measure to assess symptoms of anxiety. Scores range from 0-21 where scores greater than 10 are indicative of clinically significant anxiety.

    Measured: Baseline through study completion; repeated measure to assess change through study completion, average of 6 months

  3. Client Engagement

    Provider reported service utilization. Total number of appointments attended.

    Measured: Baseline through study completion; repeated measure to assess change through study completion, average of 6 months

  4. Client - Patient Health Questionnaire - 9

    A self-report from the individual receiving coordinated specialty care services on their symptoms of depression. Scores range from 0-27 where any score 10 or greater is indicative of clinically significant symptoms of depression.

    Measured: Baseline through study completion; repeated measure to assess change through study completion, average of 6 months

  5. Family - Patient Health Questionnaire - 9

    A self-report from the family member participant on their symptoms of depression. Scores range from 0-27 where any score 10 or greater is indicative of clinically significant symptoms of depression.

    Measured: Baseline through study completion; repeated measure to assess change through study completion, average of 6 months

  6. Community Assessment of Psychic Experiences - Positive Scale 15-items Scale

    A self-report measure from the individual receiving the coordinated specialty care services. Scores range from 0-3 where scores greater than 1.46 indicate clinically significant symptoms of psychosis.

    Measured: Baseline through study completion; repeated measure to assess change through study completion, average of 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Apr 2025
  2. Study start1 Mar 2025
  3. Primary completionDec 2029 (estimated)
  4. Study completionDec 2029 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Non-randomised
Intervention model
Sequential
Model description
A cluster randomized stepped wedge design with an attention control condition (n=225 dyads) lasting 18 months and an active implementation condition (n=225 dyads) lasting 30 months.
Masking
None (open label)
Enrolment
900 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06945055
Sponsor's protocol ID
144707-002
Other IDs
R01MH136132
Acronym
FAMES
Status last verified
Nov 2025
First submitted
24 Mar 2025
Last updated
23 Feb 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Oluwoye O, Stokes B, Crisanti AS, Garcia KS, Kriegel L, Puzia M, Sanchez AL, Shelton RC, Weeks DL. FAMily Motivational Engagement Strategy (FAMES) for coordinated specialty care programs: study protocol to evaluate a culturally responsive engagement intervention and equity focused implementation strategies in a hybrid type 2 randomized stepped-wedge trial. Trials. 2025 Dec 16;26(1):568. doi: 10.1186/s13063-025-09280-0.

    PubMed 41402877

Questions about this trial

What is this clinical trial studying?

A study testing FAMES in people with Family Members and Implementation, run by Washington State University at 4 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 0 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 23 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 4 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Oladunni Oluwoye, Associate Professor, Ph.D. (509-368-6805, oladunni.oluwoye@wsu.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Engagement in coordinated specialty care psychoeducation (time frame: Baseline through study completion; repeated measure to assess change through study completion, average of 3 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06945055, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Feb 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in